Treatment of Inflammatory Bowel Disease with Biologics (in patients over 15 years of age)

Please note that the clinical key documents are not designed to be printed, but to be viewed on-line. This is to ensure that the correct and most up to date version is being used. If, in exceptional circumstances, you need to print a copy, please note that the information will only be valid for 24 hours and should be read in conjunction with the Key Document Supporting Information and/or Key Document intranet page, which will provide approval and review information.

Purpose-
To ensure safe, effective and consistent practice in the prescribing, monitoring and management of Biologic medications for patients with Inflammatory Bowel Disease

Please click on the following links to access the Area prescribing committee Cytokine modulator pathways for Ulcerative colitis and Crohns disease which explain the preferred order of use for these medications.

http://www.southworcsccg.nhs.uk/about-us/area-prescribing-committee/

Indications for treatment

NICE Guidelines

Inpatients use of biologics

Biologic daycase checklist

Patient Screening pre treatment

Tuberculosis assessment and exclusion guidelines

Following succesful completion of the pre-screening checks and patient counselling as to the risks of these medications they may then be started on Biologic medication.

The patient must be registered as a new patient on Blueteq (CCG approval system for high cost drugs) via www.blueteq-secure.co.uk/Trust/default.htm (for Worcestershire CCGs only) select requests and then complete the appropriate initiation form.

Blueteq must also be completed when a treatment is stopped (selecting 'end of treatment'). A new request for that patient should be submitted for any subsequent biologics.